Stop Calling Everything a Partnership.

The pharmacy industry does not need more partnership language. It needs relationships designed to create and share measurable value.

STEADY STATE ADVISORS PERSPECTIVE

Partnership may be the most widely used and least consistently defined word in healthcare.

We call customers partners. We call vendors partners. We call purchasing arrangements partnerships. We describe programs as collaborative even when one party designed the model, another party performs the work and a third party captures most of the value.

The language is not the real problem. The problem is that imprecise language allows organizations to avoid a more important question: Did we build a relationship capable of producing better results for everyone it depends on?

A contract connects organizations. It does not align them

A contract can define prices, responsibilities, service levels and protections. Those elements matter. But they do not automatically create a shared objective or a functioning operating model.

Many relationships begin with enthusiasm at the executive level and weaken as they reach implementation. The strategic intent is not translated into frontline workflow. The economics do not reflect the work required. Data is available but not shared in a form that supports decisions. Measures reward activity rather than outcomes. When performance falls short, each participant retreats to the language of the contract.

That is not a failure of goodwill. It is a failure of design.

Five tests of a real partnership

First, the parties can name the same problem. If one organization believes the goal is access, another believes it is volume and another believes it is cost reduction, the relationship is already operating with competing definitions of success.

Second, the economics are sufficiently visible. Transparency does not require exposing every internal detail. It does require understanding who invests, who performs the work, who receives the financial benefit and whether the model remains viable when conditions change.

Third, operational ownership is explicit. Someone must own each handoff, each exception and the decision rights needed to resolve problems. Executive sponsorship cannot substitute for day-to-day accountability.

Fourth, value is measured across the relationship. A strong scorecard includes more than transactions completed or dollars saved. It considers patient progress, frontline burden, quality, sustainability and the consequences created elsewhere in the system.

Fifth, the model can learn. No complex pharmacy initiative survives first contact with reality unchanged. A partnership needs a trusted way to surface what is not working and improve it without turning every adjustment into a negotiation over blame.

Mutual value is not equal value

A common objection is that every participant cannot benefit equally. That is true, and it is not the standard.

Mutual value means each essential participant has a reason and the capacity to continue. The value may take different forms: patient access, sustainable economics, reduced administrative work, better adherence, faster learning, stronger customer retention or improved supply reliability. What matters is that the model does not quietly depend on one participant absorbing unrewarded work or unsustainable risk.

If a program creates attractive economics by weakening the organization responsible for execution, the model has not created value. It has transferred it.

Trust is built operationally

Healthcare leaders often speak about trust as a cultural aspiration. In practice, trust grows from repeated operating behaviors.

It grows when the difficult economic question can be discussed before it becomes a conflict. When data is used to learn rather than to punish. When one party identifies an unintended burden and the others help redesign it. When commitments survive a leadership change. When a patient problem receives more urgency than determining whose fault it is.

These behaviors sound simple. They are also a competitive advantage in an industry where organizations increasingly depend on capabilities they do not own.

Use the word carefully - and build the model deliberately

Not every commercial relationship needs to be a partnership. A clear, well-run vendor or customer relationship can be highly valuable. Calling it what it is creates healthier expectations.

When the outcome truly depends on multiple organizations changing how they work together, partnership cannot remain a positioning statement. It must be treated as an operating discipline.

The pharmacy ecosystem is too interconnected for success to be created through contracts alone. We need relationships that make the shared problem clear, the economics durable, the work executable and the impact measurable.

We should use the word partnership less often - and build the real thing more deliberately.

THE STEADY STATE QUESTION

Does each essential participant have the reason and capacity to continue creating value in this relationship?